Schwartz E L, Blair O C, Sartorelli A C
Cancer Res. 1984 Sep;44(9):3907-10.
Delayed growth arrest was observed in HL-60 acute promyelocytic leukemia cells after exposure to 6-thioguanine (TG). This growth arrest occurred in both wild-type HL-60 cells exposed to 2 microM TG and an HL-60 clone lacking hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity at a 500-fold higher concentration of drug. Both cell lines continued replication during an initial 4-day period of exposure to TG; however, upon removal of the purine antimetabolite and reincubation in fresh medium in the absence of drug, no further increase in cell number was observed over the next 4 days. Extensive differentiation, as measured by the reduction of nitroblue tetrazolium, occurred in TG-treated, HL-60 HGPRT-negative cells, whereas no significant increase in the number of nitroblue tetrazolium-positive cells was observed in wild-type HL-60 cells exposed to the purinethiol. Thus, termination of proliferation in wild-type cells appeared to be an expression of cytotoxicity, while in the HGPRT-negative clone, cell replication was apparently terminated by conversion of cells to end-stage forms with a mature phenotype. In support of this conclusion, differences occurred in the stage of the cell cycle arrest, determined on Day 6 after exposure to TG. Approximately 85% of parental HL-60 cells treated with TG were present in the S and G2 + M phases of the cell cycle, with the greatest proportional change from untreated controls being in the G2-M phase (i.e., a 63% increase over untreated controls). In contrast, HL-60 HGPRT-negative cells treated with TG accumulated in G1, with 68% of the population located in this phase (i.e., an 80% increase compared to controls), as might be expected for a differentiated population. Dimethyl sulfoxide, which produced differentiation in both parental HL-60 and HL-60 HGPRT-negative cells, was used as a positive control. Both cell lines responded identically to dimethyl sulfoxide, with growth arrest being due at least in part to differentiation, which corresponded to an increase in G1 cells.
在暴露于6-硫鸟嘌呤(TG)后,HL-60急性早幼粒细胞白血病细胞中观察到延迟生长停滞。这种生长停滞发生在暴露于2 microM TG的野生型HL-60细胞以及缺乏次黄嘌呤-鸟嘌呤磷酸核糖转移酶(HGPRT)活性的HL-60克隆中,该克隆对药物的耐受浓度高出500倍。两种细胞系在最初暴露于TG的4天期间都继续复制;然而,在去除嘌呤抗代谢物并在无药物的新鲜培养基中重新培养后,在接下来的4天中未观察到细胞数量进一步增加。通过硝基蓝四氮唑还原测定,在经TG处理的HL-60 HGPRT阴性细胞中发生了广泛分化,而在暴露于嘌呤硫醇的野生型HL-60细胞中未观察到硝基蓝四氮唑阳性细胞数量显著增加。因此,野生型细胞中增殖的终止似乎是细胞毒性的一种表现,而在HGPRT阴性克隆中,细胞复制显然是通过细胞转化为具有成熟表型的终末形式而终止的。为支持这一结论,在暴露于TG后第6天确定的细胞周期停滞阶段出现了差异。用TG处理的亲本HL-60细胞中约85%处于细胞周期的S期和G2 + M期,与未处理对照相比比例变化最大的是G2-M期(即比未处理对照增加63%)。相比之下,用TG处理的HL-60 HGPRT阴性细胞在G1期积累,68%的细胞群体处于该期(即与对照相比增加80%),这对于分化群体来说是可以预期的。在亲本HL-60和HL-60 HGPRT阴性细胞中均能诱导分化的二甲基亚砜用作阳性对照。两种细胞系对二甲基亚砜的反应相同,生长停滞至少部分是由于分化,这与G1期细胞增加相对应。